A randomized, double-blind placebo-controlled study on acceptability, safety and efficacy of oral administration of sacha inchi oil (Plukenetia volubilis L.) in adult human subjects

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 168-176

  Gonzales, Gustavo F ^a   Gonzales, Carla ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Adverse effects; Clinical trial; Linoleic acid; Linolenic acid; Lipid profile; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; ECOLINE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PREMIUM PRIMOR; PROTEIN; SACHA INCHI OIL; SUNFLOWER OIL; UNCLASSIFIED DRUG; URIC ACID; VEGETABLE OIL; LINOLEIC ACID; LIPID;

ADULT; ARTERIAL PRESSURE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERUCTATION; EUPHORBIACEAE; FATIGUE; FEMALE; FLATULENCE; HEADACHE; HEALTH STATUS; HEARTBURN; HOT FLUSH; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; LIKERT SCALE; LIPID BLOOD LEVEL; LIVER FUNCTION; MALE; MORNING DOSAGE; MUSCLE CRAMP; NAUSEA; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PLUKENETIA VOLUBILIS; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SEX DIFFERENCE; TREATMENT DURATION; VOMITING; FOOD SAFETY; MEDICINAL PLANT; PHASE 1 CLINICAL TRIAL (TOPIC); SLEEP DISORDER;

PLUKENETIA VOLUBILIS;

ADVERSE EFFECTS; CLINICAL TRIAL; LINOLEIC ACID; LINOLENIC ACID; LIPID PROFILE; TOXICITY;

ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; EUPHORBIACEAE; FEMALE; HUMANS; PLACEBOS; PLANT OILS;

EID: 84892666415     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.12.039     Document Type: Article

References (52)

1. Akinkuolie A.O., Ngwam J.S., Meigs J.B., Djoussé L. Omega-3polyunsaturatedfattyacid andinsulinsensitivity: a meta-analysis of randomized controlled trials. Clin. Nutr. 2011, 30(6):702-707.
2. Al-Bishri W.M. Favorable effects of flaxseed supplemented diet on liver and kidney functions in hypertensive wistar rats. J. Oleo Sci. 2013, 62(9):709-715.
3. Alonso J., Prieto L., Ferrer M., Vilagut G., Broquetas J.M., Roca J., Batlle J.S., Antó J.M. Testing the measurement properties of the Spanish version of the SF-36 health survey among male patients with chronic obstructive pulmonary disease. Quality of life in COPD study group. J. Clin. Epidemiol. 1998, 51(11):1087-1094.
4. Ascaso J.F., Pardo S., Real J.T., Lorente R.I., Priego A., Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diab. Care 2003, 26:3320-3325.
5. Bondioli P., Della Bella L., Rettke P. Alpha linolenic acid rich oils. Composition of Plukenetia volubilis (sacha Inchi) oil from Peru. Riv. It. Sostan. Grasse 2006, 83:120-123.
6. Bourre J.M. Dietary omega-3 fatty acids for women. Biomed. Pharmacother. 2007, 61(2-3):105-112.
7. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:85-91.
8. Buckley J.D., Howe P.R.C. Long-chain omega 3 polynsaturated fatty acids may be beneficial for reducing obesity - a review. Nutrients 2010, 2:1212-1230.
9. Bueso A., Rodríguez-Perez R., Rodríguez M., Dionicio J., Pérez-Pimiento A., Caballero M.L. Occupational allergic rhinoconjunctivitis and bronchial asthma induced by Plukenetia volubilis seeds. Occup. Environ. Med. 2010, 67(11):797-798.
10. Chan E.J., Cho L. What can we expect from omega-3 fatty acids?. Cleve. Clin. J. Med. 2009, 76(4):245-251.
11. Czernichow S., Thomas D., Bruckert E. N-6 fatty acids and cardiovascular health: dietary intake recommendations. Med. Sci. (Paris) 2011, 27(6-7):614-618. (Article in French).
12. Dostert N., Roque J., Brokamp G., Cano A., La Torre M., Weigend M. Factsheet: Datos botánicos de Sacha Inchi. Lima 2009, 3-5.
13. Drewnowski A. Energy density, palatability, and satiety: implications for weight control. Nutr. Rev. 1998, 56(12):347-353.
14. Egert S., Kannenberg F., Somoza V., Erbersdobler H.F., Wahrburg U. Dietaryalpha-linolenic acid, EPA, and DHA have differential effects on LDL fattyacidcomposition but similar effects on serum lipid profiles in normolipidemic humans. J. Nutr. 2009, 139(5):861-868.
15. Fanali C., Dugo L., Cacciola F., Beccaria M., Grasso S., Dachà M., Dugo P., Mondello L. Chemical characterization of sacha inchi (Plukenetia volubilis L.) oil. J. Agric. Food Chem. 2011, 59:13043-13049.
16. FDA., 2012. IND [Investigational new drug application] Phases of an investigation. Title 21, vol 5, Code of Federal Regulations 312.21. Washington: U.S. Government Printing Office, via GPO Access (cite 21CFR312.21]: April 1.
17. Fukumitsu, S.,Villareal, M.O.,Onaga, S.,Aida, K.,Han, J.,Isoda, H., 2012. α-Linolenicacidsuppresses cholesterol and triacylglycerol biosynthesis pathway by suppressing SREBP-2, SREBP-1a and -1c expression. Cytotechnology November 9. [Epub ahead of print].
18. Garmendia F., Pando R., Ronceros G. [Effect ofsachainchioil (Plukenetia volubilis L) on the lipid profile of patients with hyperlipoproteinemia]. Rev. Peru. Med. Exp. Salud Publica 2011, 28(4):628-632. (Article in Spanish).
19. Gazi I.F., Elisaf M. LDL-cholesterol calculation formulas in patients with or without the metabolic syndrome. Int. J. Cardiol. 2007, 119:414-415.
20. Gonzales G.F., Gonzales C., Villegas L. Exposureof fatty acids after a single oral administration of sacha inchi (Plukenetia volubilis L)) and sunflower oil in human adult subjects. Toxicol. Mech. Methods 2014.
21. Gonzales G.F., Rubio J., Gasco M. Chronic mountain sickness score was related with health status score but not with hemoglobin levels at high altitudes. Resp. Physiol. Neurobiol. 2013, 188(2):152-160.
22. Gorriti, A., Arroyo, J., Quispe, F., Cisneros, B., Condorhuaman, M., Almora, Y., Chumpitaz, V., 2010. Oral toxicity at 60-days of Sacha Inchi (Plukenetia volubilis L.) and Linseed (Linum usitatissimum L.), and determination of lethal dose 50 in rodents. Rev. Peru. Med. Exp. Salud Publica. vol. 27, 3, pp. 352-360.
23. Griffin M.D., Sanders T.A., Davies I.G., Morgan L.M., Millward D.J., Lewis F., Slaughter S., Cooper J.A., Miller G.J., Griffin B.A. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and post-prandial lipemia in men and postmenopausal women aged 45-70yr: the OPTILIP Study. Am. J. Clin. Nutr. 2006, 84:1290-1298.
24. 1HNMR. Comparison with Linseed oil. JAOCS 2003, 80(8):755-762.
25. Gillespie L. A synopsis of neotropical Plukenetia (Euphorbiaceae) including two new species. Syst. Bot. 1993, 18(4):575-592.
26. Holguin F., Téllez-Rojo M.M., Lazo M., Mannino D., Schwartz J., Hernández M., Romieu I. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 2005, 127(4):1102-1107.
27. Kaithwas G., Mukherjee A., Chaurasia A.K., Majumdar D.K. Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixedoil. Indian J. Exp. Biol. 2011, 49(12):932-938.
28. Kanno S., Kurauchi K., Tomizawa A., Yomogida S., Ishikawa M. Albumin modulates docohexaenoic acid-induced cytotoxicity in human hepatocellular carcinoma cell lines. Toxicol. Lett. 2011, 200(3):154-161.
29. Kogure R., Toyama K., Hiyamuta S., Kojima I., Takeda S. 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion. Biochem. Biophys. Res. Commun. 2011, 416:58-63.
30. Kontogianni M.D., Vlassopoulos A., Gatzieva A., Farmaki A.E., Katsiougiannis S., Panagiotakos D.B., Kalogeropoulos N., Skopouli F.N. Flaxseed oil does not affect inflammatory markers and lipid profile compared to olive oil, in young, healthy, normal weight adults. Metabolism 2013, 62(5):686-693.
31. Kremmyda L-S., Tvrzicka E., Stankova B., Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease - a review. Part 2: fatty acid physiological roles and applications in human health and disease. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2011, 155(3):195-218.
32. Kurotani K., Kochi T., Nanri A., Tsuruoka H., Kuwahara K., Pham N.M., Kabe I., Mizoue T. Plant oils were associated with low prevalence of impaired glucose metabolism in Japanese workers. PLoS One 2013, 8(5):e64758.
33. Lee S.I., Valim C., Johnston P., Le H.D., Meisel J., Arsenault D.A., Gura K.M., Puder M. Impact of fishoil-based lipid emulsion on serum triglyceride, bilirubin, andalbuminlevels in children with parenteral nutrition-associated liver disease. Pediatr. Res. 2009, 66(6):698-703.
34. Lorente-Cebrián S., Costa A.G., Navas-Carretero S., Zabala M., Martínez J.Á., Moreno-Aliaga M.J. Role ofomega-3 fatty acidsin obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J. Physiol. Biochem. 2013, 69(3):633-635.
35. Losurdo, P., Grillo, A., Panizon, E., Cappellari, G.G., Fabris, B., Bardelli, M., Biolo, G., Zanetti, M., Carretta, R., 2013. Supplementation ofOmega-3PolyunsaturatedFattyAcidsPrevents Increase inArterialStiffness After Experimental Menopause. J. Cardiovasc. Pharmacol. Ther. September 13. [Epub ahead of print].
36. Lucas M., Asselin G., Mérette C., Poulin M.J., Dodin S. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Menopause 2009, 16(2):357-366.
37. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
38. McGough C., Peacock N., Hackett C., Baldwin C., Norman A., Frost G., Blake P., Tait D., Khoo V., Harrington K., Whelan K., Andreyev H.J. Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study. Clin. Nutr. 2006, 25:906-912.
39. Monteiro J., Askarian F., Nakamura M.T., Moghadasian M.H., Ma D.W. Oils rich in α-linolenic acidindependently protect against characteristics of fatty liver disease in the δ6-desaturase null mouse. Can. J. Physiol. Pharmacol. 2013, 91(6):469-479.
40. Munro I.A., Garg M.L. Dietary supplementation with long chainomega-3polyunsaturatedfattyacidsand weight loss in obese adults. Obes. Res. Clin. Pract. 2013, 7(3):e173-e181.
41. Oh H.J., Kim T.H., Sohn Y.W., Kim Y.S., Oh Y.R., Cho E.Y., Shim S.Y., Shin S.R., Han A.L., Yoon S.J., Kim H.C. Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J. Hepatol. 2011, 17:27-36.
42. Posadzki P., Watson L.K., Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin. Med. 2013, 13(1):7-12.
43. Promperu. Evolution of the exportations of the product: Sacha Inchi. Statistics of Biocommerce. http://www.siicex.gob.pe/siicex/portal5ES.asp.
44. Pruthi S., Thompson S.L., Novotny P.J., Barton D.L., Kottschade L.A., Tan A.D., Sloan J.A., Loprinzi C.L. Pilot evaluation of flaxseed for the management ofhot flashes. J. Soc. Integr. Oncol. 2007, 5(3):106-112.
45. Root M., Collier S.R., Zwetsloot K.A., West K.L., McGinn M.C. A randomized trial of fish oilomega-3 fatty acidsonarterialhealth, inflammation, and metabolic syndrome in a young healthy population. Nutr. J. 2013, 12(1):40.
46. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol. 2009, 77:937-946.
47. Sacks F.M., Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipids and cardiovascular disease. Am. J. Med. 2002, 113:13S-24S.
48. Simão A.N., Godeny P., Lozovoy M.A., Dichi J.B., Dichi I. Effect of n-3 fatty acids in glycemic and lipid profiles, oxidative stress and total antioxidant capacity in patienets with the metabolic syndrome. Arq. Bras. Endocrinol. Metabol. 2010, 54(5):463-469.
49. Villani A.M., Crotty M., Cleland L.G., James M.J., Fraser R.J., Cobiac L., Miller M.D. Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature. BMC Geriatr. 2013, 13(1):41.
50. Wang X., Xu R., Wang R., Liu A. Transcriptome analysis ofsachainchi(Plukenetia volubilis L.) seeds at two developmental stages. BMC Genom. 2012, 13:716.
51. Yaxley A., Miller M.D., Fraser R.J., Cobiac L., Crotty M. Testing theacceptabilityof liquid fishoilin older adults. Asia Pac. J. Clin. Nutr. 2011, 20(2):175-179.
52. Young L.R., Kurzer M.S., Thomas W., Redmon J.B., Raatz S.K. Low-fat diet with omega-3 fatty acidsincreases plasmainsulin-like growth factor concentration in healthy postmenopausal women. Nutr. Res. 2013, 33(7):565-571.